The Department of Pharmaceutical Sciences and Experimental Therapeutics in the College of Pharmacy will host a special seminar with guest speaker Wensheng Yu, PhD. Yu is a principal scientist at Merck in Kenilworth, NJ. Yu will speak on the topic, "Discovery of MK-8408 (Ruzasvir) and MK-6169: 2nd generation HCV NS5A inhibitors for the treatment of HCV infection". Refreshments will be served at 10:50 am.
All are welcome to attend.
Individuals with disabilities are encouraged to attend all University of Iowa–sponsored events. If you are a person with a disability who requires a reasonable accommodation in order to participate in this program, please contact Kellie Waechter in advance at 319-335-8802 or firstname.lastname@example.org.